Extract notice to the Minister
Verzenio (Cancer du sein RH+ HER2-)
Common name / Subject : abémaciclib
Name of the manufacturer : Lilly
Form : Co.
Dosage : Toutes teneurs
Name of the manufacturer : Lilly
Form : Co.
Dosage : Toutes teneurs
Indication : Cancer du sein RH+ HER2-
INESSS' Recommendation
Modification d’une indication reconnue – Sous conditions
Minister's decisions
À venir
Evaluation published on May 13, 2026
INESSSid: 30641
Recevable on February 13, 2026